PubMed laboratory research record [PMID: 4811086] PubMed record related to this compound for laboratory literature review
Pharmaceuticals 11 , 11 (2018)
However, serious adverse effects have been reported, including risk for C-cell tumors, acute pancreatitis, acute gallbladder disease, hypoglycemia, elevated heart rate, renal impairment, hypersensitivity reactions, and suicidal behavior and ideation
Therefore, patients who have existing insurance coverage for brand name Wegovy or Zepbound will not be able to utilize Ellie MD services since it does not accept insurance coverage
The allegations are that the drug, which helps regulate type 2 diabetes and assist in weight loss, causes severe gastrointestinal problems